» Articles » PMID: 37276413

NgR1 Binding to Reovirus Reveals an Unusual Bivalent Interaction and a New Viral Attachment Protein

Abstract

Nogo-66 receptor 1 (NgR1) binds a variety of structurally dissimilar ligands in the adult central nervous system to inhibit axon extension. Disruption of ligand binding to NgR1 and subsequent signaling can improve neuron outgrowth, making NgR1 an important therapeutic target for diverse neurological conditions such as spinal crush injuries and Alzheimer's disease. Human NgR1 serves as a receptor for mammalian orthoreovirus (reovirus), but the mechanism of virus-receptor engagement is unknown. To elucidate how NgR1 mediates cell binding and entry of reovirus, we defined the affinity of interaction between virus and receptor, determined the structure of the virus-receptor complex, and identified residues in the receptor required for virus binding and infection. These studies revealed that central NgR1 surfaces form a bridge between two copies of viral capsid protein σ3, establishing that σ3 serves as a receptor ligand for reovirus. This unusual binding interface produces high-avidity interactions between virus and receptor to prime early entry steps. These studies refine models of reovirus cell-attachment and highlight the evolution of viruses to engage multiple receptors using distinct capsid components.

Citing Articles

mGem: The complexity of viral entry-one virus, many receptors.

Dermody T, Sutherland D mBio. 2025; 16(3):e0296424.

PMID: 39932305 PMC: 11898697. DOI: 10.1128/mbio.02964-24.


From viral assembly to host interaction: AFM's contributions to virology.

Ray A, Simpson J, Demir I, Gisbert V, Gomes D, Amadei F J Virol. 2024; 99(1):e0087324.

PMID: 39655953 PMC: 11784315. DOI: 10.1128/jvi.00873-24.


Strain-specific differences in reovirus infection of murine macrophages segregate with polymorphisms in viral outer-capsid protein σ3.

Fiske K, Brigleb P, Sanchez L, Hinterleitner R, Taylor G, Dermody T J Virol. 2024; 98(11):e0114724.

PMID: 39431846 PMC: 11575339. DOI: 10.1128/jvi.01147-24.


The reovirus variant RP116 is oncolytic in immunocompetent models and generates reduced neutralizing antibodies to Type 3 Dearing.

Song K, Xiang X, Lee S, Woo J, Enkhtaivan G, Giraldo C Mol Ther Oncol. 2024; 32(3):200846.

PMID: 39354956 PMC: 11442186. DOI: 10.1016/j.omton.2024.200846.


NRP1 is a receptor for mammalian orthoreovirus engaged by distinct capsid subunits.

Shang P, Dos Santos Natividade R, Taylor G, Ray A, Welsh O, Fiske K Cell Host Microbe. 2024; 32(6):980-995.e9.

PMID: 38729153 PMC: 11176008. DOI: 10.1016/j.chom.2024.04.014.

References
1.
Alsteens D, Newton R, Schubert R, Martinez-Martin D, Delguste M, Roska B . Nanomechanical mapping of first binding steps of a virus to animal cells. Nat Nanotechnol. 2016; 12(2):177-183. DOI: 10.1038/nnano.2016.228. View

2.
Clements D, Helson E, Gujar S, Lee P . Reovirus in cancer therapy: an evidence-based review. Oncolytic Virother. 2016; 3:69-82. PMC: 4918368. DOI: 10.2147/OV.S51321. View

3.
Roth A, Aravamudhan P, de Castro I, Tenorio R, Risco C, Dermody T . Ins and Outs of Reovirus: Vesicular Trafficking in Viral Entry and Egress. Trends Microbiol. 2020; 29(4):363-375. PMC: 7523517. DOI: 10.1016/j.tim.2020.09.004. View

4.
Semavina M, Saha N, Kolev M, Goldgur Y, Giger R, Himanen J . Crystal structure of the Nogo-receptor-2. Protein Sci. 2011; 20(4):684-9. PMC: 3081546. DOI: 10.1002/pro.597. View

5.
Kobayashi T, Antar A, Boehme K, Danthi P, Eby E, Guglielmi K . A plasmid-based reverse genetics system for animal double-stranded RNA viruses. Cell Host Microbe. 2007; 1(2):147-57. PMC: 2034303. DOI: 10.1016/j.chom.2007.03.003. View